Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
企業コードPMI
会社名Picard Medical Inc
上場日Aug 29, 2025
最高経営責任者「CEO」Schnegelsberg (Patrick N.J)
従業員数75
証券種類Ordinary Share
決算期末Aug 29
本社所在地1992 E. Silverlake Rd.
都市TUCSON
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国United States of America
郵便番号85713
電話番号15203080796
ウェブサイト
企業コードPMI
上場日Aug 29, 2025
最高経営責任者「CEO」Schnegelsberg (Patrick N.J)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし